Lupus Research Alliance Response to Janssen’s Ustekinumab Lupus Trial Discontinuation

June 26, 2020 The Lupus Research Alliance is disappointed at news from Janssen Pharmaceutical Companies of Johnson & Johnson that it has decided to discontinue the Phase 3 LOTUS study of ustekinumab (Stelara®) in Systemic Lupus Erythematosus (SLE). A Phase 3 trial presents data the U.S. Food and Drug Administration uses to decide whether or […] Read More